Vlad Coric

2019 - Biohaven Pharmaceutical Holding Co Ltd.

In 2019, Vlad Coric earned a total compensation of $6.8M as Chief Executive Officer at Biohaven Pharmaceutical Holding Co Ltd., a 14% decrease compared to previous year.

Compensation breakdown

Bonus$581,250
Option Awards$3,128,831
Salary$550,000
Stock Awards$2,514,120
Other$13,432
Total$6,787,633

Coric received $3.1M in option awards, accounting for 46% of the total pay in 2019.

Coric also received $581.3K in bonus, $550K in salary, $2.5M in stock awards and $13.4K in other compensation.

Rankings

In 2019, Vlad Coric's compensation ranked 1,438th out of 13,971 executives tracked by ExecPay. In other words, Coric earned more than 89.7% of executives.

ClassificationRankingPercentile
All
1,438
out of 13,971
90th
Division
Manufacturing
508
out of 5,692
91st
Major group
Chemicals And Allied Products
154
out of 2,189
93rd
Industry group
Drugs
122
out of 1,875
94th
Industry
Pharmaceutical Preparations
92
out of 1,387
93rd

Pay ratio

Vlad Coric's Pay$6,787,633
Median Employee's Pay$165,840
Pay Ratio

41

to 1

In 2019, the annual total compensation of Vlad Coric was $6,787,633.

The annual total compensation of the median employee at Biohaven Pharmaceutical Holding Co Ltd. was $165,840.

The ratio of Vlad Coric's pay to the pay of median employee was therefore 41 to one.

Source: SEC filing on March 20, 2020.

Coric's colleagues

We found four more compensation records of executives who worked with Vlad Coric at Biohaven Pharmaceutical Holding Co Ltd. in 2019.

2019

William Jones

Biohaven Pharmaceutical Holding Co Ltd.

Chief Commercial Officer of Migraine & Common Diseases

2019

Kimberly Gentile

Biohaven Pharmaceutical Holding Co Ltd.

Senior Vice President, Clinical Operations

2019

James Engelhart

Biohaven Pharmaceutical Holding Co Ltd.

Chief Financial Officer

2019

Elyse Stock

Biohaven Pharmaceutical Holding Co Ltd.

Chief Medical Officer

News

You may also like